Transient Ischemic Attack News and Research

RSS
A transient ischemic attack (TIA) is a transient stroke that lasts only a few minutes. It occurs when the blood supply to part of the brain is briefly interrupted. TIA symptoms, which usually occur suddenly, are similar to those of stroke but do not last as long. Most symptoms of a TIA disappear within an hour, although they may persist for up to 24 hours. Symptoms can include: numbness or weakness in the face, arm, or leg, especially on one side of the body; confusion or difficulty in talking or understanding speech; trouble seeing in one or both eyes; and difficulty with walking, dizziness, or loss of balance and coordination.
Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

RRE-90 score: A new web-based tool to predict recurrent stroke risk

RRE-90 score: A new web-based tool to predict recurrent stroke risk

ZYPREXA RELPREVV approved by FDA

ZYPREXA RELPREVV approved by FDA

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

MICARDIS receives Health Canada approval to reduce the risk of non-fatal stroke

MICARDIS receives Health Canada approval to reduce the risk of non-fatal stroke

Updated clinical guidelines on Effient treatment for ACS patients

Updated clinical guidelines on Effient treatment for ACS patients

Incidence of stroke related to coronary angioplasty remain steady over a 15-year period: Mayo Clinic study

Incidence of stroke related to coronary angioplasty remain steady over a 15-year period: Mayo Clinic study

Interim data from Schering-Plough's narlaprevir Phase IIa study

Interim data from Schering-Plough's narlaprevir Phase IIa study

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough receives FDA complete response letter regarding PEGINTRON

NMT Medical reports financial results for third-quarter 2009; narrows net loss to $0.22 per share

NMT Medical reports financial results for third-quarter 2009; narrows net loss to $0.22 per share

Transient ischemic attacks are treatable and preventable

Transient ischemic attacks are treatable and preventable

Dr. Shelagh Coutts receives award for developing new brain scan

Dr. Shelagh Coutts receives award for developing new brain scan

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough receives FDA recommendation approval for PEGINTRON

Schering-Plough receives FDA recommendation approval for PEGINTRON

Transient ischemic attack can trigger stroke

Transient ischemic attack can trigger stroke

Merck update on the status of telcagepant clinical development programs

Merck update on the status of telcagepant clinical development programs

Free, online self-assessment quiz helps assess health and lifestyle risks for PAD

Free, online self-assessment quiz helps assess health and lifestyle risks for PAD

The Kyoto Heart study shows positive effect of valsartan on cardiovascular outcome

The Kyoto Heart study shows positive effect of valsartan on cardiovascular outcome